Hot Topics
Coming June 21: Celesq® adds a new Intellectual Property Hot Topic CLE program to its web cast schedule
April 4, 2012–Celesq® AttorneysEd Center has added a new CLE program, Supreme Court/Federal Circuit En Banc Intellectual Property Review: 2011-2012 Term, from the Celesq®-West LegalEdcenter IP Master Series (2233IP), to its upcoming web cast schedule. This program and two recent additions to Celesq®’s May web cast schedule cover hot topics in Intellectual Property Law for IP practitioners and litigators and for corporate attorneys as well.
The May-June programs are:
Supreme Court/Federal Circuit En Banc Intellectual Property Review: 2011-2012 Term (2233IP)
June 21, 2012 (12:00 noon ET)
Anthony Lo Cicero, Amster, Rothstein & Ebenstein LLP, discusses Mayo Collaborative Services v. Prometheus Laboratories, Inc., Association for Molecular Pathology v. Myriad Genetics, et al., Therasence, Inc. v. Becton, Dickinson and Co., and Marine Polymer Technologies, Inc. v. Hemcon, Inc., and the likely impact of each on IP practitioners and companies.
For details concerning the live web cast, click here.
For details concerning the on demand and CD versions on Celesq®, click here.
Patent Litigation Discovery in the Eastern District of Texas: The Rules Have Changed! (2230IP)
May 17, 2012 (12:00 noon ET)
McDermott Will & Emery partners Dan Foster and Leigh Martinson discuss the new Model E-Discovery Rules issued by the District Court in the Eastern District of Texas (formally known as [Model] Order Regarding E-Discovery in Patent Cases).
For details concerning the live web cast, click here.
For details concerning the on demand and CD versions on Celesq®, click here.
Divided Patent Infringement and Infringement by Use—The Standards Revisited (2231IP)
May 30, 2012 (12:00 noon ET)
Amster, Rothstein & Ebenstein partner Anthony Lo Cicero discusses the highly-anticipated Federal Circuit’s en banc decision in the Akamai and McKesson cases, which is expected to provide much- needed guidance on such issues as whether each infringing step or claim element must be performed by a single actor and who is responsible for “use” of an invention.
For details concerning the live web cast, click here.
For details concerning the on demand and CD versions on Celesq®, click here.
View all Hot Topics
